Pharmaceuticals, Biotechnology and Life Sciences
BERKELEY HEIGHTS, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”),…
New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in…
PORTLAND, Ore., Dec. 22, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a…
Ad hoc announcement pursuant to Art. 53 LR With two maintenance doses a year, Leqvio is the first and only…
FORT WORTH, TX , Dec. 22, 2021 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a…
MONMOUTH JUNCTION, N.J., Dec. 22, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the…
– Successful nomination of lead SAFEbody candidates triggers milestone payment – SAN DIEGO and SUZHOU, China, Dec. 22, 2021 (GLOBE…
FDA has set a target action date of July 29, 2022NDA supported by positive efficacy data from the pivotal Phase…
VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today…
§ Provista completed validation for fingerprick At-Home sample collection of blood for the cPass neutralizing antibody test New York, NY, and…